UnitedHealth's stock has fallen about 48% due to pressure from Medicare Advantage margin compression and operational challenges. However, a higher-than-expected 2027 Medicare Advantage rate increase of 2.48% is expected to add around $1 billion in operating profit, supporting a margin recovery in 2026. The company’s management has implemented aggressive repricing, benefit reductions, and cost controls, aiming for over $24 billion in operating earnings and a 30 basis point margin improvement. Additionally, strong performance from Optum Rx and Optum Insight, with Insight delivering over 22% margins, provides a stable earnings base beyond insurance pressures.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
